3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Motor Activity
9
Neoplasms
7
Breast Neoplasms
6
Pancreatic Neoplasms
3
Malnutrition
3
Laryngeal Neoplasms
3
Head and Neck Neoplasms
3
Prostatic Neoplasms
2
Pharyngeal Neoplasms
2
Obesity
2
Lung Neoplasms
2
Liver Neoplasms
2
Diabetes Mellitus, Type 2
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Weight Loss
1
Undefined
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcopenia
1
Rectal Neoplasms
1
Pancreatitis, Chronic
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neurotoxicity Syndromes
1
Mouth Neoplasms
1
Lung Diseases
1
Liver Diseases
1
Hypopharyngeal Neoplasms
1
Hematologic Neoplasms
1
Interventions
Carboplatin
19
Pemetrexed
10
Paclitaxel
7
pembrolizumab
5
Nivolumab
5
Cisplatin
5
Gemcitabine
4
osimertinib
3
entinostat
3
camrelizumab
3
atezolizumab
3
Erlotinib Hydrochloride
3
zipalertinib
2
selpercatinib
2
pralsetinib
2
durvalumab
2
apatinib
2
Vinorelbine
2
Surveys and Questionnaires
2
One-Lung Ventilation
2
Ipilimumab
2
Docetaxel
2
Bevacizumab
2
130-nm albumin-bound paclitaxel
2
zimberelimab
1
toripalimab
1
spartalizumab
1
sotorasib
1
sitravatinib
1
sintilimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Lung Diseases
×
Nutritional Status
×
Clear all
NCT04666558
2022-10-04
PiONEeR
University of Alberta
Phase NA
Completed
216 enrolled